Alps Group Inc (ALPS)
NASDAQ: ALPS · Real-Time Price · USD
0.8850
+0.0250 (2.91%)
At close: May 15, 2026, 4:00 PM EDT
0.9200
+0.0350 (3.95%)
After-hours: May 15, 2026, 4:17 PM EDT
Alps Group Market Cap
Alps Group has a market cap or net worth of $147.26 million as of May 15, 2026.
Market Cap
147.26M
Enterprise Value
143.24M
1-Year Change
n/a
Ranking
Category
Stock Price
$0.89
Market Cap Chart
Since October 31, 2025, Alps Group's market cap has increased from $88.76M to $147.26M, an increase of 65.92%. That is a compound annual growth rate of 157.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 14, 2026 | 3.03M | -5.03% |
| Dec 31, 2025 | 3.19M | -96.41% |
| Oct 31, 2025 | 88.76M | - |
View and export this data all the way back to 2025. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Connect Biopharma Holdings | 151.48M |
| Molecular Partners AG | 150.18M |
| Galectin Therapeutics | 148.11M |
| Spero Therapeutics | 147.07M |
| Equillium | 143.52M |
| Agenus | 142.89M |
| NeOnc Technologies Holdings | 138.79M |
| Innate Pharma | 137.51M |